AI Article Synopsis

  • * RGS14 recruits to the plasma membrane to interact with GPCRs and is involved in regulating G protein signaling, though its exact effects on G signaling are less understood compared to conventional RGS proteins like RGS4.
  • * Experimental comparisons showed that both RGS14 and RGS4 act as GTPase activating proteins (GAPs) to enhance G deactivation speed, but RGS14’s GPR motif operates independently

Article Abstract

RGS14 is a multifunctional scaffolding protein possessing two distinct G protein interaction sites including a regulator of G protein signaling (RGS) domain that acts as a GTPase activating protein (GAP) to deactivate Gi/o-GTP proteins, and a G protein regulatory (GPR) motif that binds inactive Gi1/3-GDP proteins independent of G. GPR interactions with Gi recruit RGS14 to the plasma membrane to interact with Gi-linked GPCRs and regulate Gi signaling. While RGS14 actions on G proteins are well characterized, consequent effects on G signaling remain unknown. Conventional RGS proteins act as dedicated GAPs to deactivate G and G signaling following receptor activation. RGS14 may do the same or, alternatively, may coordinate its actions to deactivate G-GTP with the RGS domain and then capture the same G-GDP via its GPR motif to prevent heterotrimer reassociation and prolong G signaling. To test this idea, we compared the regulation of G protein activation and deactivation kinetics by a conventional RGS protein, RGS4, and RGS14 in response to GPCR agonist/antagonist treatment utilizing bioluminescence resonance energy transfer (BRET). Co-expression of either RGS4 or RGS14 inhibited the release of free G after agonist stimulation and increased the deactivation rate of G, consistent with their roles as GTPase activating proteins (GAPs). Overexpression of inactive Gi1 to recruit RGS14 to the plasma membrane did not alter RGS14's capacity to act as a GAP for a second Go protein. These results demonstrate the role of RGS14 as a dedicated GAP and suggest that the G protein regulatory (GPR) motif functions independently of the RGS domain and is silent in regulating GAP activity in a cellular context.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045935PMC
http://dx.doi.org/10.1002/prp2.249DOI Listing

Publication Analysis

Top Keywords

rgs domain
12
gpr motif
12
rgs14
9
protein
9
prolong signaling
8
signaling receptor
8
receptor activation
8
gtpase activating
8
protein regulatory
8
regulatory gpr
8

Similar Publications

Here we describe a neonate exhibiting hypotonia, macrocephaly, renal cysts, and respiratory failure requiring tracheostomy and ventilator support. Genetic analysis via rapid genome sequencing (rGS) identified a loss on chromosome 4 encompassing polycystin-2 (PKD2) and a loss on chromosome 22 encompassing SH3 and Multiple Ankyrin Repeat Domains 3 (SHANK3), indicative of Phelan-McDermid syndrome. Further analysis via traditional karyotyping, Optical Genome Mapping (OGM), and PacBio long-read sequencing revealed a more complex landscape of chromosomal rearrangements in this individual, including a balanced 3;12 translocation, and an unbalanced 17;22 translocation.

View Article and Find Full Text PDF

Bipolar disorder's etiology involves genetics, environmental factors, and gene-environment interactions, underlying its heterogeneous nature and treatment complexity. In 2020, Forstner and colleagues catalogued 378 sequence variants co-segregating with familial bipolar disorder. A notable candidate was an R59Q missense mutation in the PDZ (PSD-95/Dlg1/ZO-1) domain of RGS12.

View Article and Find Full Text PDF
Article Synopsis
  • - Over the last 30 years, miniaturized percutaneous nephrolithotomy (mPCNL) has gained popularity due to its potential to reduce complications compared to standard procedures, but there's still debate over best practices and management strategies that hinders wider use.
  • - An international panel of urology experts developed a consensus document on mPCNL to provide a comprehensive framework for practice, which included reviewing literature, identifying research gaps, and conducting surveys to gather expert opinions.
  • - The study revealed 58 key questions on mPCNL practices, and consensus was achieved on 30 questions, affirming mPCNL as an effective technique for treating upper urinary tract stones in both adults and children.
View Article and Find Full Text PDF

A gain of function variant in RGS18 candidate for a familial mild bleeding syndrome.

J Thromb Haemost

October 2024

National Institute of Health and Medical Research, National Research Institute for Agriculture, Food and Environment, Research Center for Cardiovascular and Nutrition, Faculty of Medicine, Aix Marseille University, Marseille, France; Reference Center on Constitutional Platelet Disorders, Biogenopole, University Hospital Center Timone, Public Assistance - Hospitals of Marseille, Marseille, France. Electronic address:

Background: Inherited platelet diseases are bleeding disorders characterized by either defects in platelet count or platelet function, the latter being less common and very heterogeneous. Numerous gene variants associated with abnormal receptors, granules, and signaling pathways have been reported. Despite significant advancements in our understanding, many patients still lack a precise diagnosis.

View Article and Find Full Text PDF

AXIN1 boosts antiviral response through IRF3 stabilization and induced phase separation.

Signal Transduct Target Ther

October 2024

Department of Experimental Research, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou, P. R. China.

Article Synopsis
  • AXIN1 is a crucial scaffold protein that regulates cell fate and plays a significant role in antiviral immunity against both DNA and RNA viruses.
  • It stabilizes the transcription factor IRF3 by preventing its degradation and increases IRF3 phosphorylation during viral infections, enhancing the production of interferon.
  • The small molecule KYA1797K improves AXIN1 and IRF3 interactions, potentially serving as an effective antiviral treatment, with reduced AXIN1 levels linked to poorer survival rates in HBV-associated liver cancer patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!